Your browser doesn't support javascript.
loading
Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders.
Rajmohan, Ravi; Baveja, Shivali; Nguyen, Dai; Shah, Eshita; Sy, Michael; Attaripour, Sanaz; Swope, David.
Afiliación
  • Rajmohan R; Department of Neurology, University of California, Irvine, CA, United States.
  • Baveja S; School of Medicine, University of California, Irvine, CA, United States.
  • Nguyen D; Department of Internal Medicine, University of California, Davis, CA, United States.
  • Shah E; Department of Neurology, University of California, Irvine, CA, United States.
  • Sy M; Department of Neurology, University of California, Irvine, CA, United States.
  • Attaripour S; Department of Neurology, University of California, Irvine, CA, United States.
  • Swope D; Department of Neurology, University of California, Irvine, CA, United States.
Front Immunol ; 14: 1297340, 2023.
Article en En | MEDLINE | ID: mdl-38259445
ABSTRACT

Background:

Glutamic acid decarboxylase antibody-spectrum disorders (GAD-SDs) include a group of autoimmune neurological diseases associated with neuronal excitability, most noticeably stiff person syndrome. Immune modulators are the mainstay of treatment, but a significant number of patients remain refractory.

Methods:

We present our single-center experience of eight cases of GAD-SD, two of which were refractory to immune modulatory treatments.

Results:

Of the two cases that were refractory to immunomodulation, one showed significant improvement with bilateral globus pallidus interna deep brain stimulation (GPi DBS) placement, and the other showed significant improvement with autologous hematopoietic stem cell transplant (aHSCT).

Discussion:

To our knowledge, this is the first instance of GPi DBS placement being noted to improve GAD-SD movements.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes del Sistema Nervioso / Glutamato Descarboxilasa Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes del Sistema Nervioso / Glutamato Descarboxilasa Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article